Početna › Mikrocelularni karcinom pluća › New Jersey
Kliničke studije za Mikrocelularni karcinom pluća u državi New Jersey
17 studija za Mikrocelularni karcinom pluća traži sudionike na lokacijama u državi New Jersey.
Gradovi u državi New Jersey
Službeni tekst studije (engleski)
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- John Theurer Cancer Center at Hackensack UMC, Hackensack
U tijeku regrutacijaFaza 1
Od 19 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06586957Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- MSK Basking Ridge, Basking Ridge
- MSK Monmouth, Middletown
- MSK Bergen., Montvale
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07476287A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Inspira Medical Center Mullica Hill /ID# 280574, Mullica Hill
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07365241Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- United Theranostics, Princeton
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07278479A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Hackensack University Medical Center, Hackensack
- Rutgers Cancer Institute of New Jersey, New Brunswick
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07488676BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
- Astera Cancer Care, East Brunswick
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT07625644A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 1103), Hackensack
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06780137A Study of Armored CAR T Cells in People With Cancer
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT07783477Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
- Morristown Medical Center, Morristown
- Rutgers Cancer Institute, New Brunswick
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. kol 2026. · NCT07057791A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- Regional Cancer Care Associates, Belleville
- John Theurer Cancer Center at Hackensack UMC, Hackensack
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 26. kol 2026. · NCT06892548A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
- Hackensack University Medical Center, Hackensack
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 25. kol 2026. · NCT07488923A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT06807632A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Astera Cancer Care, East Brunswick
- Hackensack Meridian Health Jsumc, Neptune City
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT06203210A Study of LY4175408 in Participants With Advanced Cancer
- John Theurer Cancer Center At Hackensack UMC, Hackensack
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. lip 2026. · NCT07046923A Study of Hospital-at-Home for People Receiving Tarlatamab
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 12. lip 2026. · NCT06957314A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
- Memorial Sloan Kettering at Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 10. lip 2026. · NCT05419076VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Englewood Hospital and Medical Center (site 202), Englewood
- Summit Medical Group (site 205), Florham Park
- Atlantic Health System, Morristown Medical Center (site 124), Morristown
U tijeku regrutacijaFaza 1/2
Od 18 do 80 godina · Oba spola · Ažurirano 11. pro 2025. · NCT03556228Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.